nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—ABCG2—Vandetanib—thyroid cancer	0.267	0.451	CbGbCtD
Riluzole—ABCG2—Sorafenib—thyroid cancer	0.161	0.272	CbGbCtD
Riluzole—ABCG2—Doxorubicin—thyroid cancer	0.0976	0.165	CbGbCtD
Riluzole—CYP1A2—Sorafenib—thyroid cancer	0.0663	0.112	CbGbCtD
Riluzole—Hypokalaemia—Epirubicin—thyroid cancer	0.00028	0.000691	CcSEcCtD
Riluzole—Diarrhoea—Sorafenib—thyroid cancer	0.00028	0.000691	CcSEcCtD
Riluzole—Breast disorder—Epirubicin—thyroid cancer	0.000278	0.000686	CcSEcCtD
Riluzole—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000277	0.000684	CcSEcCtD
Riluzole—Face oedema—Doxorubicin—thyroid cancer	0.000275	0.000678	CcSEcCtD
Riluzole—Gastritis—Epirubicin—thyroid cancer	0.000272	0.000672	CcSEcCtD
Riluzole—Muscular weakness—Epirubicin—thyroid cancer	0.000271	0.00067	CcSEcCtD
Riluzole—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000271	0.00067	CcSEcCtD
Riluzole—Cardiac arrest—Doxorubicin—thyroid cancer	0.00027	0.000668	CcSEcCtD
Riluzole—Dizziness—Sorafenib—thyroid cancer	0.00027	0.000668	CcSEcCtD
Riluzole—Mood swings—Doxorubicin—thyroid cancer	0.000269	0.000665	CcSEcCtD
Riluzole—Abdominal distension—Epirubicin—thyroid cancer	0.000267	0.000661	CcSEcCtD
Riluzole—Ataxia—Doxorubicin—thyroid cancer	0.000267	0.00066	CcSEcCtD
Riluzole—Dysphagia—Epirubicin—thyroid cancer	0.000266	0.000656	CcSEcCtD
Riluzole—Asthma—Epirubicin—thyroid cancer	0.000266	0.000656	CcSEcCtD
Riluzole—Influenza—Epirubicin—thyroid cancer	0.000266	0.000656	CcSEcCtD
Riluzole—Dehydration—Doxorubicin—thyroid cancer	0.000264	0.000653	CcSEcCtD
Riluzole—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000263	0.000649	CcSEcCtD
Riluzole—Pancreatitis—Epirubicin—thyroid cancer	0.00026	0.000643	CcSEcCtD
Riluzole—Vomiting—Sorafenib—thyroid cancer	0.00026	0.000642	CcSEcCtD
Riluzole—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00026	0.000642	CcSEcCtD
Riluzole—Hypokalaemia—Doxorubicin—thyroid cancer	0.000259	0.000639	CcSEcCtD
Riluzole—Angina pectoris—Epirubicin—thyroid cancer	0.000259	0.000639	CcSEcCtD
Riluzole—Rash—Sorafenib—thyroid cancer	0.000258	0.000637	CcSEcCtD
Riluzole—Dermatitis—Sorafenib—thyroid cancer	0.000257	0.000636	CcSEcCtD
Riluzole—Breast disorder—Doxorubicin—thyroid cancer	0.000257	0.000635	CcSEcCtD
Riluzole—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000256	0.000633	CcSEcCtD
Riluzole—Headache—Sorafenib—thyroid cancer	0.000256	0.000632	CcSEcCtD
Riluzole—Bronchitis—Epirubicin—thyroid cancer	0.000255	0.000631	CcSEcCtD
Riluzole—Pancytopenia—Epirubicin—thyroid cancer	0.000252	0.000623	CcSEcCtD
Riluzole—Gastritis—Doxorubicin—thyroid cancer	0.000252	0.000622	CcSEcCtD
Riluzole—Muscular weakness—Doxorubicin—thyroid cancer	0.000251	0.00062	CcSEcCtD
Riluzole—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000251	0.00062	CcSEcCtD
Riluzole—Dysuria—Epirubicin—thyroid cancer	0.000248	0.000614	CcSEcCtD
Riluzole—Neutropenia—Epirubicin—thyroid cancer	0.000248	0.000614	CcSEcCtD
Riluzole—Abdominal distension—Doxorubicin—thyroid cancer	0.000247	0.000611	CcSEcCtD
Riluzole—Influenza—Doxorubicin—thyroid cancer	0.000246	0.000607	CcSEcCtD
Riluzole—Asthma—Doxorubicin—thyroid cancer	0.000246	0.000607	CcSEcCtD
Riluzole—Dysphagia—Doxorubicin—thyroid cancer	0.000246	0.000607	CcSEcCtD
Riluzole—Pollakiuria—Epirubicin—thyroid cancer	0.000245	0.000606	CcSEcCtD
Riluzole—Nausea—Sorafenib—thyroid cancer	0.000243	0.0006	CcSEcCtD
Riluzole—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000242	0.000599	CcSEcCtD
Riluzole—Weight increased—Epirubicin—thyroid cancer	0.000242	0.000597	CcSEcCtD
Riluzole—Pancreatitis—Doxorubicin—thyroid cancer	0.000241	0.000595	CcSEcCtD
Riluzole—Weight decreased—Epirubicin—thyroid cancer	0.00024	0.000594	CcSEcCtD
Riluzole—Angina pectoris—Doxorubicin—thyroid cancer	0.000239	0.000591	CcSEcCtD
Riluzole—Pneumonia—Epirubicin—thyroid cancer	0.000238	0.000588	CcSEcCtD
Riluzole—Infestation NOS—Epirubicin—thyroid cancer	0.000237	0.000585	CcSEcCtD
Riluzole—Infestation—Epirubicin—thyroid cancer	0.000237	0.000585	CcSEcCtD
Riluzole—Bronchitis—Doxorubicin—thyroid cancer	0.000236	0.000584	CcSEcCtD
Riluzole—Pancytopenia—Doxorubicin—thyroid cancer	0.000233	0.000577	CcSEcCtD
Riluzole—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000232	0.000573	CcSEcCtD
Riluzole—Jaundice—Epirubicin—thyroid cancer	0.000231	0.00057	CcSEcCtD
Riluzole—Stomatitis—Epirubicin—thyroid cancer	0.000231	0.00057	CcSEcCtD
Riluzole—Urinary tract infection—Epirubicin—thyroid cancer	0.00023	0.000569	CcSEcCtD
Riluzole—Neutropenia—Doxorubicin—thyroid cancer	0.00023	0.000568	CcSEcCtD
Riluzole—Dysuria—Doxorubicin—thyroid cancer	0.00023	0.000568	CcSEcCtD
Riluzole—Sweating—Epirubicin—thyroid cancer	0.000227	0.000561	CcSEcCtD
Riluzole—Pollakiuria—Doxorubicin—thyroid cancer	0.000227	0.000561	CcSEcCtD
Riluzole—Haematuria—Epirubicin—thyroid cancer	0.000226	0.000558	CcSEcCtD
Riluzole—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000224	0.000554	CcSEcCtD
Riluzole—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000224	0.000553	CcSEcCtD
Riluzole—Weight increased—Doxorubicin—thyroid cancer	0.000224	0.000553	CcSEcCtD
Riluzole—Epistaxis—Epirubicin—thyroid cancer	0.000223	0.000552	CcSEcCtD
Riluzole—Weight decreased—Doxorubicin—thyroid cancer	0.000222	0.000549	CcSEcCtD
Riluzole—Sinusitis—Epirubicin—thyroid cancer	0.000222	0.000549	CcSEcCtD
Riluzole—Agranulocytosis—Epirubicin—thyroid cancer	0.000221	0.000546	CcSEcCtD
Riluzole—Pneumonia—Doxorubicin—thyroid cancer	0.00022	0.000544	CcSEcCtD
Riluzole—Infestation NOS—Doxorubicin—thyroid cancer	0.000219	0.000541	CcSEcCtD
Riluzole—Infestation—Doxorubicin—thyroid cancer	0.000219	0.000541	CcSEcCtD
Riluzole—Bradycardia—Epirubicin—thyroid cancer	0.000216	0.000535	CcSEcCtD
Riluzole—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000215	0.000531	CcSEcCtD
Riluzole—Haemoglobin—Epirubicin—thyroid cancer	0.000214	0.000528	CcSEcCtD
Riluzole—Stomatitis—Doxorubicin—thyroid cancer	0.000214	0.000528	CcSEcCtD
Riluzole—Jaundice—Doxorubicin—thyroid cancer	0.000214	0.000528	CcSEcCtD
Riluzole—Rhinitis—Epirubicin—thyroid cancer	0.000213	0.000527	CcSEcCtD
Riluzole—Urinary tract infection—Doxorubicin—thyroid cancer	0.000213	0.000526	CcSEcCtD
Riluzole—Haemorrhage—Epirubicin—thyroid cancer	0.000213	0.000525	CcSEcCtD
Riluzole—Hepatitis—Epirubicin—thyroid cancer	0.000213	0.000525	CcSEcCtD
Riluzole—Hypoaesthesia—Epirubicin—thyroid cancer	0.000212	0.000523	CcSEcCtD
Riluzole—Pharyngitis—Epirubicin—thyroid cancer	0.000211	0.000521	CcSEcCtD
Riluzole—Sweating—Doxorubicin—thyroid cancer	0.00021	0.000519	CcSEcCtD
Riluzole—SLC7A11—Amino acid and oligopeptide SLC transporters—SLC5A5—thyroid cancer	0.00021	0.0599	CbGpPWpGaD
Riluzole—Urinary tract disorder—Epirubicin—thyroid cancer	0.00021	0.000519	CcSEcCtD
Riluzole—Oedema peripheral—Epirubicin—thyroid cancer	0.000209	0.000517	CcSEcCtD
Riluzole—Haematuria—Doxorubicin—thyroid cancer	0.000209	0.000516	CcSEcCtD
Riluzole—Connective tissue disorder—Epirubicin—thyroid cancer	0.000209	0.000516	CcSEcCtD
Riluzole—Urethral disorder—Epirubicin—thyroid cancer	0.000208	0.000515	CcSEcCtD
Riluzole—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000207	0.000512	CcSEcCtD
Riluzole—Epistaxis—Doxorubicin—thyroid cancer	0.000207	0.000511	CcSEcCtD
Riluzole—Sinusitis—Doxorubicin—thyroid cancer	0.000206	0.000508	CcSEcCtD
Riluzole—Agranulocytosis—Doxorubicin—thyroid cancer	0.000204	0.000505	CcSEcCtD
Riluzole—Erythema multiforme—Epirubicin—thyroid cancer	0.000201	0.000497	CcSEcCtD
Riluzole—Bradycardia—Doxorubicin—thyroid cancer	0.0002	0.000495	CcSEcCtD
Riluzole—Eye disorder—Epirubicin—thyroid cancer	0.000199	0.000491	CcSEcCtD
Riluzole—Haemoglobin—Doxorubicin—thyroid cancer	0.000198	0.000488	CcSEcCtD
Riluzole—Cardiac disorder—Epirubicin—thyroid cancer	0.000197	0.000487	CcSEcCtD
Riluzole—Rhinitis—Doxorubicin—thyroid cancer	0.000197	0.000487	CcSEcCtD
Riluzole—Haemorrhage—Doxorubicin—thyroid cancer	0.000197	0.000486	CcSEcCtD
Riluzole—Hepatitis—Doxorubicin—thyroid cancer	0.000197	0.000486	CcSEcCtD
Riluzole—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000196	0.000483	CcSEcCtD
Riluzole—Pharyngitis—Doxorubicin—thyroid cancer	0.000195	0.000482	CcSEcCtD
Riluzole—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000194	0.00048	CcSEcCtD
Riluzole—Oedema peripheral—Doxorubicin—thyroid cancer	0.000194	0.000479	CcSEcCtD
Riluzole—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000193	0.000478	CcSEcCtD
Riluzole—Angiopathy—Epirubicin—thyroid cancer	0.000193	0.000476	CcSEcCtD
Riluzole—Urethral disorder—Doxorubicin—thyroid cancer	0.000193	0.000476	CcSEcCtD
Riluzole—Immune system disorder—Epirubicin—thyroid cancer	0.000192	0.000474	CcSEcCtD
Riluzole—Mediastinal disorder—Epirubicin—thyroid cancer	0.000192	0.000473	CcSEcCtD
Riluzole—Chills—Epirubicin—thyroid cancer	0.000191	0.000471	CcSEcCtD
Riluzole—Arrhythmia—Epirubicin—thyroid cancer	0.00019	0.000469	CcSEcCtD
Riluzole—Alopecia—Epirubicin—thyroid cancer	0.000188	0.000464	CcSEcCtD
Riluzole—Mental disorder—Epirubicin—thyroid cancer	0.000186	0.00046	CcSEcCtD
Riluzole—Erythema multiforme—Doxorubicin—thyroid cancer	0.000186	0.000459	CcSEcCtD
Riluzole—Malnutrition—Epirubicin—thyroid cancer	0.000185	0.000457	CcSEcCtD
Riluzole—Eye disorder—Doxorubicin—thyroid cancer	0.000184	0.000454	CcSEcCtD
Riluzole—Cardiac disorder—Doxorubicin—thyroid cancer	0.000183	0.000451	CcSEcCtD
Riluzole—Flatulence—Epirubicin—thyroid cancer	0.000182	0.00045	CcSEcCtD
Riluzole—Tension—Epirubicin—thyroid cancer	0.000182	0.000449	CcSEcCtD
Riluzole—Dysgeusia—Epirubicin—thyroid cancer	0.000181	0.000448	CcSEcCtD
Riluzole—Nervousness—Epirubicin—thyroid cancer	0.00018	0.000444	CcSEcCtD
Riluzole—Back pain—Epirubicin—thyroid cancer	0.000179	0.000442	CcSEcCtD
Riluzole—Angiopathy—Doxorubicin—thyroid cancer	0.000178	0.000441	CcSEcCtD
Riluzole—Muscle spasms—Epirubicin—thyroid cancer	0.000178	0.00044	CcSEcCtD
Riluzole—Immune system disorder—Doxorubicin—thyroid cancer	0.000178	0.000439	CcSEcCtD
Riluzole—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000177	0.000438	CcSEcCtD
Riluzole—Chills—Doxorubicin—thyroid cancer	0.000176	0.000436	CcSEcCtD
Riluzole—Arrhythmia—Doxorubicin—thyroid cancer	0.000176	0.000434	CcSEcCtD
Riluzole—Alopecia—Doxorubicin—thyroid cancer	0.000174	0.000429	CcSEcCtD
Riluzole—Mental disorder—Doxorubicin—thyroid cancer	0.000172	0.000426	CcSEcCtD
Riluzole—Ill-defined disorder—Epirubicin—thyroid cancer	0.000172	0.000424	CcSEcCtD
Riluzole—Malnutrition—Doxorubicin—thyroid cancer	0.000171	0.000423	CcSEcCtD
Riluzole—Anaemia—Epirubicin—thyroid cancer	0.000171	0.000423	CcSEcCtD
Riluzole—Agitation—Epirubicin—thyroid cancer	0.00017	0.00042	CcSEcCtD
Riluzole—Flatulence—Doxorubicin—thyroid cancer	0.000169	0.000417	CcSEcCtD
Riluzole—Tension—Doxorubicin—thyroid cancer	0.000168	0.000415	CcSEcCtD
Riluzole—Dysgeusia—Doxorubicin—thyroid cancer	0.000168	0.000414	CcSEcCtD
Riluzole—Malaise—Epirubicin—thyroid cancer	0.000167	0.000412	CcSEcCtD
Riluzole—Nervousness—Doxorubicin—thyroid cancer	0.000166	0.000411	CcSEcCtD
Riluzole—Vertigo—Epirubicin—thyroid cancer	0.000166	0.000411	CcSEcCtD
Riluzole—Syncope—Epirubicin—thyroid cancer	0.000166	0.00041	CcSEcCtD
Riluzole—Leukopenia—Epirubicin—thyroid cancer	0.000166	0.000409	CcSEcCtD
Riluzole—Back pain—Doxorubicin—thyroid cancer	0.000166	0.000409	CcSEcCtD
Riluzole—Muscle spasms—Doxorubicin—thyroid cancer	0.000165	0.000407	CcSEcCtD
Riluzole—Palpitations—Epirubicin—thyroid cancer	0.000164	0.000404	CcSEcCtD
Riluzole—Loss of consciousness—Epirubicin—thyroid cancer	0.000163	0.000402	CcSEcCtD
Riluzole—Cough—Epirubicin—thyroid cancer	0.000161	0.000399	CcSEcCtD
Riluzole—Convulsion—Epirubicin—thyroid cancer	0.00016	0.000396	CcSEcCtD
Riluzole—Hypertension—Epirubicin—thyroid cancer	0.00016	0.000395	CcSEcCtD
Riluzole—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000159	0.000392	CcSEcCtD
Riluzole—Anaemia—Doxorubicin—thyroid cancer	0.000158	0.000391	CcSEcCtD
Riluzole—Arthralgia—Epirubicin—thyroid cancer	0.000158	0.000389	CcSEcCtD
Riluzole—Chest pain—Epirubicin—thyroid cancer	0.000158	0.000389	CcSEcCtD
Riluzole—Myalgia—Epirubicin—thyroid cancer	0.000158	0.000389	CcSEcCtD
Riluzole—Agitation—Doxorubicin—thyroid cancer	0.000157	0.000389	CcSEcCtD
Riluzole—Anxiety—Epirubicin—thyroid cancer	0.000157	0.000388	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000156	0.000387	CcSEcCtD
Riluzole—Discomfort—Epirubicin—thyroid cancer	0.000156	0.000385	CcSEcCtD
Riluzole—Malaise—Doxorubicin—thyroid cancer	0.000154	0.000381	CcSEcCtD
Riluzole—Dry mouth—Epirubicin—thyroid cancer	0.000154	0.000381	CcSEcCtD
Riluzole—Vertigo—Doxorubicin—thyroid cancer	0.000154	0.00038	CcSEcCtD
Riluzole—Syncope—Doxorubicin—thyroid cancer	0.000154	0.000379	CcSEcCtD
Riluzole—Leukopenia—Doxorubicin—thyroid cancer	0.000153	0.000379	CcSEcCtD
Riluzole—Confusional state—Epirubicin—thyroid cancer	0.000152	0.000376	CcSEcCtD
Riluzole—Palpitations—Doxorubicin—thyroid cancer	0.000151	0.000374	CcSEcCtD
Riluzole—Oedema—Epirubicin—thyroid cancer	0.000151	0.000373	CcSEcCtD
Riluzole—Anaphylactic shock—Epirubicin—thyroid cancer	0.000151	0.000373	CcSEcCtD
Riluzole—Loss of consciousness—Doxorubicin—thyroid cancer	0.000151	0.000372	CcSEcCtD
Riluzole—Infection—Epirubicin—thyroid cancer	0.00015	0.000371	CcSEcCtD
Riluzole—Cough—Doxorubicin—thyroid cancer	0.000149	0.000369	CcSEcCtD
Riluzole—Shock—Epirubicin—thyroid cancer	0.000149	0.000367	CcSEcCtD
Riluzole—Convulsion—Doxorubicin—thyroid cancer	0.000148	0.000367	CcSEcCtD
Riluzole—Nervous system disorder—Epirubicin—thyroid cancer	0.000148	0.000366	CcSEcCtD
Riluzole—Thrombocytopenia—Epirubicin—thyroid cancer	0.000148	0.000365	CcSEcCtD
Riluzole—Hypertension—Doxorubicin—thyroid cancer	0.000148	0.000365	CcSEcCtD
Riluzole—Tachycardia—Epirubicin—thyroid cancer	0.000147	0.000364	CcSEcCtD
Riluzole—Skin disorder—Epirubicin—thyroid cancer	0.000147	0.000362	CcSEcCtD
Riluzole—Hyperhidrosis—Epirubicin—thyroid cancer	0.000146	0.000361	CcSEcCtD
Riluzole—Chest pain—Doxorubicin—thyroid cancer	0.000146	0.00036	CcSEcCtD
Riluzole—Arthralgia—Doxorubicin—thyroid cancer	0.000146	0.00036	CcSEcCtD
Riluzole—Myalgia—Doxorubicin—thyroid cancer	0.000146	0.00036	CcSEcCtD
Riluzole—Anxiety—Doxorubicin—thyroid cancer	0.000145	0.000359	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000145	0.000358	CcSEcCtD
Riluzole—Discomfort—Doxorubicin—thyroid cancer	0.000144	0.000356	CcSEcCtD
Riluzole—Anorexia—Epirubicin—thyroid cancer	0.000144	0.000356	CcSEcCtD
Riluzole—Dry mouth—Doxorubicin—thyroid cancer	0.000143	0.000352	CcSEcCtD
Riluzole—Hypotension—Epirubicin—thyroid cancer	0.000141	0.000349	CcSEcCtD
Riluzole—Confusional state—Doxorubicin—thyroid cancer	0.000141	0.000348	CcSEcCtD
Riluzole—Oedema—Doxorubicin—thyroid cancer	0.00014	0.000345	CcSEcCtD
Riluzole—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00014	0.000345	CcSEcCtD
Riluzole—Infection—Doxorubicin—thyroid cancer	0.000139	0.000343	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000138	0.00034	CcSEcCtD
Riluzole—Shock—Doxorubicin—thyroid cancer	0.000137	0.00034	CcSEcCtD
Riluzole—Nervous system disorder—Doxorubicin—thyroid cancer	0.000137	0.000339	CcSEcCtD
Riluzole—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000137	0.000338	CcSEcCtD
Riluzole—Insomnia—Epirubicin—thyroid cancer	0.000137	0.000337	CcSEcCtD
Riluzole—Tachycardia—Doxorubicin—thyroid cancer	0.000136	0.000337	CcSEcCtD
Riluzole—Skin disorder—Doxorubicin—thyroid cancer	0.000136	0.000335	CcSEcCtD
Riluzole—Paraesthesia—Epirubicin—thyroid cancer	0.000136	0.000335	CcSEcCtD
Riluzole—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000135	0.000334	CcSEcCtD
Riluzole—Dyspnoea—Epirubicin—thyroid cancer	0.000135	0.000333	CcSEcCtD
Riluzole—Somnolence—Epirubicin—thyroid cancer	0.000134	0.000332	CcSEcCtD
Riluzole—Anorexia—Doxorubicin—thyroid cancer	0.000133	0.000329	CcSEcCtD
Riluzole—Dyspepsia—Epirubicin—thyroid cancer	0.000133	0.000328	CcSEcCtD
Riluzole—Decreased appetite—Epirubicin—thyroid cancer	0.000131	0.000324	CcSEcCtD
Riluzole—Hypotension—Doxorubicin—thyroid cancer	0.000131	0.000323	CcSEcCtD
Riluzole—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00013	0.000322	CcSEcCtD
Riluzole—Fatigue—Epirubicin—thyroid cancer	0.00013	0.000322	CcSEcCtD
Riluzole—Constipation—Epirubicin—thyroid cancer	0.000129	0.000319	CcSEcCtD
Riluzole—Pain—Epirubicin—thyroid cancer	0.000129	0.000319	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000127	0.000315	CcSEcCtD
Riluzole—Insomnia—Doxorubicin—thyroid cancer	0.000126	0.000312	CcSEcCtD
Riluzole—Paraesthesia—Doxorubicin—thyroid cancer	0.000125	0.00031	CcSEcCtD
Riluzole—Dyspnoea—Doxorubicin—thyroid cancer	0.000125	0.000308	CcSEcCtD
Riluzole—Feeling abnormal—Epirubicin—thyroid cancer	0.000124	0.000307	CcSEcCtD
Riluzole—Somnolence—Doxorubicin—thyroid cancer	0.000124	0.000307	CcSEcCtD
Riluzole—SLC7A11—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.000124	0.0353	CbGpPWpGaD
Riluzole—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000124	0.000305	CcSEcCtD
Riluzole—Dyspepsia—Doxorubicin—thyroid cancer	0.000123	0.000304	CcSEcCtD
Riluzole—Decreased appetite—Doxorubicin—thyroid cancer	0.000121	0.0003	CcSEcCtD
Riluzole—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000121	0.000298	CcSEcCtD
Riluzole—Fatigue—Doxorubicin—thyroid cancer	0.00012	0.000298	CcSEcCtD
Riluzole—Urticaria—Epirubicin—thyroid cancer	0.00012	0.000296	CcSEcCtD
Riluzole—Pain—Doxorubicin—thyroid cancer	0.00012	0.000295	CcSEcCtD
Riluzole—Constipation—Doxorubicin—thyroid cancer	0.00012	0.000295	CcSEcCtD
Riluzole—Abdominal pain—Epirubicin—thyroid cancer	0.000119	0.000295	CcSEcCtD
Riluzole—Body temperature increased—Epirubicin—thyroid cancer	0.000119	0.000295	CcSEcCtD
Riluzole—CYP1A1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000118	0.0336	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000115	0.0329	CbGpPWpGaD
Riluzole—Feeling abnormal—Doxorubicin—thyroid cancer	0.000115	0.000284	CcSEcCtD
Riluzole—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000114	0.000282	CcSEcCtD
Riluzole—ABCG2—Iron uptake and transport—CP—thyroid cancer	0.000113	0.0322	CbGpPWpGaD
Riluzole—Hypersensitivity—Epirubicin—thyroid cancer	0.000111	0.000275	CcSEcCtD
Riluzole—Urticaria—Doxorubicin—thyroid cancer	0.000111	0.000274	CcSEcCtD
Riluzole—Abdominal pain—Doxorubicin—thyroid cancer	0.00011	0.000273	CcSEcCtD
Riluzole—Body temperature increased—Doxorubicin—thyroid cancer	0.00011	0.000273	CcSEcCtD
Riluzole—Asthenia—Epirubicin—thyroid cancer	0.000108	0.000268	CcSEcCtD
Riluzole—Pruritus—Epirubicin—thyroid cancer	0.000107	0.000264	CcSEcCtD
Riluzole—ABCG2—HIF-2-alpha transcription factor network—EPO—thyroid cancer	0.000107	0.0305	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—RET—thyroid cancer	0.000105	0.0299	CbGpPWpGaD
Riluzole—Diarrhoea—Epirubicin—thyroid cancer	0.000103	0.000255	CcSEcCtD
Riluzole—Hypersensitivity—Doxorubicin—thyroid cancer	0.000103	0.000254	CcSEcCtD
Riluzole—Asthenia—Doxorubicin—thyroid cancer	0.0001	0.000248	CcSEcCtD
Riluzole—Dizziness—Epirubicin—thyroid cancer	9.99e-05	0.000247	CcSEcCtD
Riluzole—Pruritus—Doxorubicin—thyroid cancer	9.89e-05	0.000244	CcSEcCtD
Riluzole—ABCG2—Fluoropyrimidine Activity—SMUG1—thyroid cancer	9.76e-05	0.0278	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—THRB—thyroid cancer	9.75e-05	0.0278	CbGpPWpGaD
Riluzole—Vomiting—Epirubicin—thyroid cancer	9.6e-05	0.000237	CcSEcCtD
Riluzole—Diarrhoea—Doxorubicin—thyroid cancer	9.56e-05	0.000236	CcSEcCtD
Riluzole—Rash—Epirubicin—thyroid cancer	9.52e-05	0.000235	CcSEcCtD
Riluzole—Dermatitis—Epirubicin—thyroid cancer	9.51e-05	0.000235	CcSEcCtD
Riluzole—Headache—Epirubicin—thyroid cancer	9.46e-05	0.000234	CcSEcCtD
Riluzole—Dizziness—Doxorubicin—thyroid cancer	9.24e-05	0.000228	CcSEcCtD
Riluzole—Nausea—Epirubicin—thyroid cancer	8.97e-05	0.000222	CcSEcCtD
Riluzole—Vomiting—Doxorubicin—thyroid cancer	8.89e-05	0.00022	CcSEcCtD
Riluzole—Rash—Doxorubicin—thyroid cancer	8.81e-05	0.000218	CcSEcCtD
Riluzole—Dermatitis—Doxorubicin—thyroid cancer	8.8e-05	0.000217	CcSEcCtD
Riluzole—SLC7A11—NRF2 pathway—SLC5A5—thyroid cancer	8.77e-05	0.025	CbGpPWpGaD
Riluzole—Headache—Doxorubicin—thyroid cancer	8.75e-05	0.000216	CcSEcCtD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—NRG1—thyroid cancer	8.49e-05	0.0242	CbGpPWpGaD
Riluzole—Nausea—Doxorubicin—thyroid cancer	8.3e-05	0.000205	CcSEcCtD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—CP—thyroid cancer	8.01e-05	0.0228	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	7.98e-05	0.0227	CbGpPWpGaD
Riluzole—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	7.52e-05	0.0214	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—TPR—thyroid cancer	7.38e-05	0.0211	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—CP—thyroid cancer	7.38e-05	0.0211	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—RXRA—thyroid cancer	7.37e-05	0.021	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	7.35e-05	0.021	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	6.48e-05	0.0185	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—NRG1—thyroid cancer	6.37e-05	0.0182	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—EPO—thyroid cancer	6.28e-05	0.0179	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	5.53e-05	0.0158	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—CHST14—thyroid cancer	5.37e-05	0.0153	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—SST—thyroid cancer	5.12e-05	0.0146	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PRKAR1A—thyroid cancer	4.26e-05	0.0122	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—TERT—thyroid cancer	3.91e-05	0.0112	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—NRAS—thyroid cancer	3.89e-05	0.0111	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—TPR—thyroid cancer	3.75e-05	0.0107	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—CP—thyroid cancer	3.75e-05	0.0107	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	3.74e-05	0.0107	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.69e-05	0.0105	CbGpPWpGaD
Riluzole—CYP1A1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	3.68e-05	0.0105	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	3.42e-05	0.00976	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—KRAS—thyroid cancer	3.34e-05	0.00954	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	3.08e-05	0.00877	CbGpPWpGaD
Riluzole—CYP1A1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.98e-05	0.00851	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—HRAS—thyroid cancer	2.84e-05	0.00811	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—IFNA2—thyroid cancer	2.82e-05	0.00806	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.81e-05	0.00801	CbGpPWpGaD
Riluzole—ABCG2—Fluoropyrimidine Activity—TP53—thyroid cancer	2.59e-05	0.00739	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—CDK1—thyroid cancer	2.49e-05	0.00709	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.36e-05	0.00673	CbGpPWpGaD
Riluzole—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.35e-05	0.00669	CbGpPWpGaD
Riluzole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	2.33e-05	0.00666	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—RXRA—thyroid cancer	2.27e-05	0.00646	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	2.26e-05	0.00645	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	2.22e-05	0.00632	CbGpPWpGaD
Riluzole—CYP1A1—Arachidonic acid metabolism—PTGS2—thyroid cancer	2.11e-05	0.00603	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.9e-05	0.00543	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—CDK1—thyroid cancer	1.77e-05	0.00506	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	1.76e-05	0.00502	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—MINPP1—thyroid cancer	1.72e-05	0.00491	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.68e-05	0.0048	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—RXRA—thyroid cancer	1.65e-05	0.0047	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—RXRA—thyroid cancer	1.58e-05	0.00452	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	1.53e-05	0.00436	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	1.51e-05	0.00432	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NDUFA13—thyroid cancer	1.46e-05	0.00417	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	1.44e-05	0.00411	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	1.43e-05	0.00408	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	1.4e-05	0.00399	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CHST14—thyroid cancer	1.37e-05	0.00392	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	1.36e-05	0.00388	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	1.36e-05	0.00388	CbGpPWpGaD
Riluzole—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.35e-05	0.00385	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.34e-05	0.00381	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	1.29e-05	0.00367	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.26e-05	0.00359	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MINPP1—thyroid cancer	1.16e-05	0.00332	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	1.12e-05	0.0032	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HPGD—thyroid cancer	1.11e-05	0.00316	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.07e-05	0.00306	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—NRAS—thyroid cancer	1.05e-05	0.003	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PPARG—thyroid cancer	1.04e-05	0.00297	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.02e-05	0.0029	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—RXRA—thyroid cancer	1.01e-05	0.00288	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NDUFA13—thyroid cancer	9.9e-06	0.00282	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	9.65e-06	0.00275	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	9.65e-06	0.00275	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CHST14—thyroid cancer	9.31e-06	0.00265	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—KRAS—thyroid cancer	9.07e-06	0.00259	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—NRAS—thyroid cancer	8.92e-06	0.00254	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.55e-06	0.00244	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	8.2e-06	0.00234	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TP53—thyroid cancer	8.06e-06	0.0023	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—HRAS—thyroid cancer	7.71e-06	0.0022	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—KRAS—thyroid cancer	7.68e-06	0.00219	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HPGD—thyroid cancer	7.5e-06	0.00214	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MINPP1—thyroid cancer	7.42e-06	0.00212	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—AKT1—thyroid cancer	6.81e-06	0.00194	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—HRAS—thyroid cancer	6.52e-06	0.00186	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—TPR—thyroid cancer	6.37e-06	0.00182	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—NRAS—thyroid cancer	6.36e-06	0.00182	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NDUFA13—thyroid cancer	6.31e-06	0.0018	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PRKAR1A—thyroid cancer	6.26e-06	0.00179	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.09e-06	0.00174	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CHST14—thyroid cancer	5.93e-06	0.00169	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—KRAS—thyroid cancer	5.48e-06	0.00156	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HPGD—thyroid cancer	4.78e-06	0.00136	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC5A5—thyroid cancer	4.76e-06	0.00136	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—HRAS—thyroid cancer	4.66e-06	0.00133	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TPR—thyroid cancer	4.31e-06	0.00123	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	4.24e-06	0.00121	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—AKT1—thyroid cancer	4.11e-06	0.00117	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—RXRA—thyroid cancer	4e-06	0.00114	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.88e-06	0.00111	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.84e-06	0.0011	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC5A5—thyroid cancer	3.23e-06	0.00092	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.02e-06	0.000862	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TPR—thyroid cancer	2.75e-06	0.000784	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—RXRA—thyroid cancer	2.71e-06	0.000773	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	2.7e-06	0.000771	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.64e-06	0.000752	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PPARG—thyroid cancer	2.53e-06	0.000721	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.45e-06	0.000699	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC5A5—thyroid cancer	2.06e-06	0.000587	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS2—thyroid cancer	1.99e-06	0.000567	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.93e-06	0.00055	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTEN—thyroid cancer	1.73e-06	0.000495	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—RXRA—thyroid cancer	1.73e-06	0.000493	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPARG—thyroid cancer	1.71e-06	0.000488	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.68e-06	0.000479	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS2—thyroid cancer	1.35e-06	0.000384	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTEN—thyroid cancer	1.17e-06	0.000335	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPARG—thyroid cancer	1.09e-06	0.000311	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AKT1—thyroid cancer	9.99e-07	0.000285	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS2—thyroid cancer	8.58e-07	0.000245	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTEN—thyroid cancer	7.48e-07	0.000213	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AKT1—thyroid cancer	6.77e-07	0.000193	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AKT1—thyroid cancer	4.31e-07	0.000123	CbGpPWpGaD
